RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 28 filers reported holding RAPT THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,453,347 | +2.8% | 628,886 | +15.6% | 0.00% | 0.0% |
Q2 2023 | $10,171,871 | +4.9% | 543,950 | +2.9% | 0.00% | 0.0% |
Q1 2023 | $9,698,990 | +107582.8% | 528,555 | +16.2% | 0.00% | 0.0% |
Q4 2022 | $9,007 | -99.9% | 454,906 | +7.0% | 0.00% | -50.0% |
Q3 2022 | $10,228,000 | +37.9% | 425,143 | +4.6% | 0.00% | +100.0% |
Q2 2022 | $7,417,000 | -9.0% | 406,432 | +9.7% | 0.00% | 0.0% |
Q1 2022 | $8,149,000 | -35.5% | 370,591 | +7.7% | 0.00% | -50.0% |
Q4 2021 | $12,635,000 | +17.3% | 344,014 | -0.8% | 0.00% | +100.0% |
Q3 2021 | $10,770,000 | +48.9% | 346,867 | +52.4% | 0.00% | 0.0% |
Q2 2021 | $7,235,000 | +92.3% | 227,588 | +34.3% | 0.00% | 0.0% |
Q1 2021 | $3,763,000 | +32.4% | 169,513 | +17.7% | 0.00% | – |
Q4 2020 | $2,843,000 | -35.9% | 143,975 | +4.4% | 0.00% | -100.0% |
Q3 2020 | $4,438,000 | +16.4% | 137,844 | +4.9% | 0.00% | 0.0% |
Q2 2020 | $3,813,000 | +154.2% | 131,396 | +86.2% | 0.00% | – |
Q1 2020 | $1,500,000 | -8.1% | 70,552 | +19.2% | 0.00% | – |
Q4 2019 | $1,632,000 | – | 59,172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |